日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Liver Transplantation After Prolonged Nab-Sirolimus Therapy for Unresectable Hepatic Perivascular Epithelioid Cell Tumor With Bilobar Involvement

长期接受白蛋白结合型西罗莫司治疗后行肝移植治疗不可切除的双侧肝叶受累的肝血管周围上皮样细胞肿瘤

Cruz, Andrew John; Russell, Dylan; Cheng, Phillip M; Agulnik, Mark; Chopra, Shefali; Sturdevant, Mark; Kaur, Navpreet; Kahn, Jeffrey A

Botensilimab (Fc-enhanced anti-cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti-PD-1 antibody) in Patients With Relapsed/Refractory Metastatic Sarcomas

Botensilimab(Fc增强型抗细胞毒性淋巴细胞相关蛋白-4抗体)联合Balstilimab(抗PD-1抗体)治疗复发/难治性转移性肉瘤患者

Wilky, Breelyn A; Schwartz, Gary K; Gordon, Michael S; El-Khoueiry, Anthony B; Bullock, Andrea J; Henick, Brian; Agulnik, Mark; Singh, Arun; Mahadevan, Daruka; Stebbing, Justin; Delepine, Chloe; Chand, Dhan; Avagyan, Manushak; Wu, Wei; Johnson, Benny; Grossman, Joseph E; O'Day, Steven; Trent, Jonathan C; Jones, Robin L; Tsimberidou, Apostolia M

Sarcoma: Cardiovascular and Oncologic Considerations: JACC: CardioOncology State-of-the-Art Review

肉瘤:心血管和肿瘤学考量:JACC:心血管肿瘤学最新进展综述

Lefler, Daniel S; Nassif Haddad, Elise F; Nohria, Anju; Agulnik, Mark; Crane, Jacquelyn; Fradley, Michael G

Cabozantinib Plus Ipilimumab/Nivolumab in Patients With Previously Treated Advanced Differentiated Thyroid Cancer

卡博替尼联合伊匹木单抗/纳武利尤单抗治疗既往接受过治疗的晚期分化型甲状腺癌患者

Konda, Bhavana; Sherman, Eric J; Massarelli, Erminia; Nieva, Jorge; Muzaffar, Jameel; Morris, John C 3rd; Ryder, Mabel; Ho, Alan L; Agulnik, Mark; Wei, Lai; Handley, Demond; Moses, Catherine; Jacob, Rajani; Wright, John; Streicher, Howard; Carson, William; Shah, Manisha H

Real-world survival outcomes and MDM2 prevalence in US patients with metastatic dedifferentiated liposarcoma

美国转移性去分化脂肪肉瘤患者的真实世界生存结果和MDM2患病率

Robinson, Steven; Klein, Alyssa B; Stanhope, Stephen A; Evans, Kathryn; Agulnik, Mark

Durable disease regression with copanlisib treatment in PI3K-mutated metastasizing ameloblastoma: A case report

copanlisib治疗PI3K突变转移性成釉细胞瘤可实现持久的疾病缓解:病例报告

Lynch, Meghan M; Hermida-Viveiros, Pedro; Stencel, Sean; Knott, Hannah; Al-Maryati, Rusul; Obeidin, Farres; Alexiev, Borislav A; Abbinanti, Susan; Damodaran, Senthil; Agulnik, Mark; Pollack, Seth M

Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial

Afamitresgene autoleucel 用于晚期滑膜肉瘤和黏液样圆形细胞脂肪肉瘤(SPEARHEAD-1):一项国际性、开放标签的 II 期试验

D'Angelo, Sandra P; Araujo, Dejka M; Abdul Razak, Albiruni R; Agulnik, Mark; Attia, Steven; Blay, Jean-Yves; Carrasco Garcia, Irene; Charlson, John A; Choy, Edwin; Demetri, George D; Druta, Mihaela; Forcade, Edouard; Ganjoo, Kristen N; Glod, John; Keedy, Vicki L; Le Cesne, Axel; Liebner, David A; Moreno, Victor; Pollack, Seth M; Schuetze, Scott M; Schwartz, Gary K; Strauss, Sandra J; Tap, William D; Thistlethwaite, Fiona; Valverde Morales, Claudia Maria; Wagner, Michael J; Wilky, Breelyn A; McAlpine, Cheryl; Hudson, Laura; Navenot, Jean-Marc; Wang, Tianjiao; Bai, Jane; Rafail, Stavros; Wang, Ruoxi; Sun, Amy; Fernandes, Lilliam; Van Winkle, Erin; Elefant, Erica; Lunt, Colin; Norry, Elliot; Williams, Dennis; Biswas, Swethajit; Van Tine, Brian A

Prices and Trends in FDA-Approved Medications for Sarcomas

FDA批准的肉瘤药物的价格和趋势

Hwang, Caleb; Agulnik, Mark; Schulte, Brian

SMARCA4 / BRG1 -deficient Uterine Neoplasm With Hybrid Adenosarcoma and Carcinoma Features: Expanding the Molecular-morphologic Spectrum of SMARCA4 -driven Gynecologic Malignancies

SMARCA4/BRG1缺陷型子宫肿瘤具有腺肉瘤和癌的混合特征:扩展SMARCA4驱动的妇科恶性肿瘤的分子形态学谱

Wei, Christina H; Sadimin, Evita; Agulnik, Mark; Yost, Susan E; Longacre, Teri A; Fadare, Oluwole

Diffuse intra-abdominal sarcomatosis in myxoid pleomorphic liposarcoma

黏液样多形性脂肪肉瘤的弥漫性腹腔内肉瘤病

Tseng, William W; Liang, Yu; Nguyen, Bao; Agulnik, Mark; Creytens, David